|
Volumn 8, Issue 12, 1999, Pages 1981-2008
|
Recent advances in the development of telomerase inhibitors for the treatment of cancer
a a |
Author keywords
Antisense; Cancer; Chemotherapy; G quadruplex; hTERT; Oligonucleotide; Reverse transcriptase inhibitor; Telomerase; Telomerase inhibitor; Telomere; Tetraplex DNA
|
Indexed keywords
1 ETHYL 2 [[3 ETHYL 5 (3 METHYLBENZOTHIAZOLIN 2 YLIDENE) 4 OXOTHIAZOLIDIN 2 YLIDENE]METHYL]PYRIDINIUM CHLORIDE;
9 HYDROXYELLIPTICINE;
ACRIDINE DERIVATIVE;
ANTHRAQUINONE DERIVATIVE;
ANTINEOPLASTIC AGENT;
ANTISENSE OLIGODEOXYNUCLEOTIDE;
CISPLATIN;
COMPLEMENTARY RNA;
DNA;
DOXORUBICIN;
ENZYME INHIBITOR;
EPIGALLOCATECHIN GALLATE;
ETHIDIUM BROMIDE;
FLUORENONE DERIVATIVE;
GUANOSINE TRIPHOSPHATE DERIVATIVE;
LEVOFLOXACIN;
NUCLEOSIDE TRIPHOSPHATE;
OFLOXACIN;
PERYLENE;
PORPHYRIN DERIVATIVE;
PROTEIN KINASE C INHIBITOR;
QUINONE DERIVATIVE;
RNA DIRECTED DNA POLYMERASE INHIBITOR;
SPHINGOSINE;
TELOMERASE;
TELOMERASE INHIBITOR;
TEMOZOLOMIDE;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
ZIDOVUDINE;
ZIDOVUDINE 5' TRIPHOSPHATE;
CANCER;
CANCER CELL CULTURE;
CANCER CHEMOTHERAPY;
DIAGNOSTIC VALUE;
DNA BINDING;
ENZYME ACTIVITY;
GENE EXPRESSION REGULATION;
HUMAN;
NONHUMAN;
REVIEW;
TELOMERE;
|
EID: 0032739776
PISSN: 13543784
EISSN: None
Source Type: Journal
DOI: 10.1517/13543784.8.12.1981 Document Type: Review |
Times cited : (47)
|
References (168)
|